Wilma Bilger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wilma Bilger has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Klaus Bühler
Scientific Clinical Centre for Endometriosis, University Hospitals of Saarland, Saarbrücken, Germany; Department of Gynaecology, Jena-University Hospital-Friedrich Schiller University, Jena, Germany
1 shared publication - Olaf Gj Naether
Reproductive Endocrinology, MVZ Fertility Center Hamburg, Hamburg, Germany
1 shared publication
Latest Publications
- Open Access
- 1 January 2014
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 12 (1) , 6
A large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology
Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) both have a role to play in follicular development during the natural menstrual cycle. LH supplementation during controlled ovarian stimulation (COS) for assisted reproductive technology (ART) is used for patients with hypogonadotropic hypogonadism. However, the use of exogenous LH in COS in normogonadotropic women undergoing ART is the subject of debate. The aim of this study was to investigate characteristics of infertile women who received the 2:1 formulation of follitropin alfa and lutropin alfa (indicated for stimulation of follicular development in women with severe LH and FSH deficiency) in German clinical practice.
- 1 January 2014
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 12 (1) , 6
Open AccessA large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology
Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) both have a role to play in follicular development during the natural menstrual cycle. LH supplementation during controlled ovarian stimulation (COS) for assisted reproductive technology (ART) is used for patients with hypogonadotropic hypogonadism. However, the use of exogenous LH in COS in normogonadotropic women undergoing ART is the subject of debate. The aim of this study was to investigate characteristics of infertile women who received the 2:1 formulation of follitropin alfa and lutropin alfa (indicated for stimulation of follicular development in women with severe LH and FSH deficiency) in German clinical practice.